BWAY
Brainsway Ltd
NASDAQ: BWAY · HEALTHCARE · MEDICAL DEVICES
$15.88
-1.37% today
Updated 2026-04-29
Market cap
$655.34M
P/E ratio
90.94
P/S ratio
12.55x
EPS (TTM)
$0.18
Dividend yield
—
52W range
$4 – $17
Volume
0.2M
Brainsway Ltd (BWAY) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$15.88
12-Month target
$6.75
2030 Target
$9.55
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 19.00% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 14.50%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.